| Health promotion at work: A comparison of policy and practice across Europe SE Verra, A Benzerga, B Jiao, K Ruggeri Safety and Health at Work 10 (1), 21-29, 2019 | 93 | 2019 |
| Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance KM Johnson, B Jiao, SD Ramsey, MA Bender, B Devine, A Basu Blood Advances 7 (3), 365-374, 2023 | 62 | 2023 |
| Living with parents or grandparents increases social capital and survival: 2014 General Social Survey-National Death Index P Muennig, B Jiao, E Singer SSM-population health 4, 71-75, 2018 | 50 | 2018 |
| Decision analysis model for prehospital triage of patients with acute stroke Y Xu, NS Parikh, B Jiao, JZ Willey, AK Boehme, MSV Elkind Stroke 50 (4), 970-977, 2019 | 49 | 2019 |
| The cost-effectiveness of PHQ screening and collaborative care for depression in New York City B Jiao, Z Rosen, M Bellanger, G Belkin, P Muennig PloS one 12 (8), e0184210, 2017 | 44 | 2017 |
| Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies LP Garrison Jr, B Jiao, O Dabbous Journal of managed care & specialty pharmacy 27 (5), 674-681, 2021 | 33 | 2021 |
| Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries B Jiao, KM Johnson, SD Ramsey, MA Bender, B Devine, A Basu Blood Advances 7 (13), 3276-3283, 2023 | 31 | 2023 |
| The cost-effectiveness of bike share expansion to low-income communities in New York city W Yu, C Chen, B Jiao, Z Zafari, P Muennig Journal of urban health 95, 888-898, 2018 | 25 | 2018 |
| Medical and non-medical costs of sickle cell disease and treatments from a US perspective: a systematic review and landscape analysis Z Baldwin, B Jiao, A Basu, J Roth, MA Bender, Z Elsisi, KM Johnson, ... PharmacoEconomics-Open 6 (4), 469-481, 2022 | 21 | 2022 |
| Economic evaluation of urine-based or magnetic resonance imaging reflex tests in men with intermediate prostate-specific antigen levels in the United States B Jiao, R Gulati, N Hendrix, JL Gore, S Rais-Bahrami, TM Morgan, ... Value in Health 24 (8), 1111-1117, 2021 | 21 | 2021 |
| A quantitative framework to study potential benefits and harms of multi-cancer early detection testing B Jiao, R Gulati, HA Katki, PE Castle, R Etzioni Cancer Epidemiology, Biomarkers & Prevention 31 (1), 38-44, 2022 | 20 | 2022 |
| Use of real-world evidence in economic assessments of pharmaceuticals in the United States W Lee, V Dayer, B Jiao, JJ Carlson, B Devine, DL Veenstra Journal of Managed Care & Specialty Pharmacy 27 (1), 5-14, 2021 | 20 | 2021 |
| Catalog of age-and medical condition—specific healthcare costs in the United States to inform future costs calculations in cost-effectiveness analysis B Jiao, A Basu Value in Health 24 (7), 957-965, 2021 | 17 | 2021 |
| The cost-effectiveness of lowering permissible noise levels around US airports B Jiao, Z Zafari, B Will, K Ruggeri, S Li, P Muennig International Journal of Environmental Research and Public Health 14 (12), 1497, 2017 | 17 | 2017 |
| The cost-effectiveness of competing congestion pricing plans in New York city W Yu, D Suh, S Song, B Jiao, L Zhang, P Muennig Journal of Transport & Health 14, 100586, 2019 | 13 | 2019 |
| Clarifying the trade-offs of risk-stratified screening for prostate cancer: a cost-effectiveness study N Hendrix, R Gulati, B Jiao, AK Kader, ST Ryan, R Etzioni American journal of epidemiology 190 (10), 2064-2074, 2021 | 12 | 2021 |
| Cost-effectiveness of neighbourhood slow zones in New York City B Jiao, S Kim, J Hagen, PA Muennig Injury prevention 25 (2), 98-103, 2019 | 12 | 2019 |
| Associating health-related quality-of-life score with time uses to inform productivity measures in cost-effectiveness analysis B Jiao, A Basu Pharmacoeconomics 41 (9), 1065-1077, 2023 | 10 | 2023 |
| The use of cost-effectiveness analysis in sickle cell disease: a critical review of the literature B Jiao, A Basu, J Roth, M Bender, I Rovira, T Clemons, D Quach, ... Pharmacoeconomics 39 (11), 1225-1241, 2021 | 10 | 2021 |
| Value-based pricing for patent-protected medicines over the product life cycle: pricing anomalies in the “Age of Cures” and their implications for dynamic efficiency LP Garrison Jr, B Jiao, O Dabbous Value in Health 26 (3), 336-343, 2023 | 9 | 2023 |
